{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:21:56Z","timestamp":1784208116507,"version":"3.55.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T00:00:00Z","timestamp":1414713600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0111816","type":"journal-article","created":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T14:17:14Z","timestamp":1414765034000},"page":"e111816","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["Genetic Determinants of On-Aspirin Platelet Reactivity: Focus on the Influence of PEAR1"],"prefix":"10.1371","volume":"9","author":[{"given":"Morten","family":"W\u00fcrtz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik Lerkevang","family":"Grove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen Dalby","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Mette","family":"Hvas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,10,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"C Baigent","year":"2009","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","article-title":"Aspirin \u201cresistance\u201d and risk of cardiovascular morbidity: systematic review and meta-analysis","volume":"336","author":"G Krasopoulos","year":"2008","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.2174\/138161212803251925","article-title":"Interindividual variability in the efficacy of oral antiplatelet drugs: definitions, mechanisms and clinical importance","volume":"18","author":"M Wurtz","year":"2012","journal-title":"Curr Pharm Des"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.jacc.2011.12.062","article-title":"Genes and Coronary Artery Disease: Where Are We?","volume":"60","author":"R Roberts","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1161\/01.CIR.103.25.3051","article-title":"Genetic and environmental contributions to platelet aggregation: the Framingham heart study","volume":"103","author":"CJ O'Donnell","year":"2001","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1161\/CIRCULATIONAHA.106.667584","article-title":"Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1","volume":"115","author":"N Faraday","year":"2007","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"C Patrono","year":"2005","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1161\/01.CIR.0000093279.36628.12","article-title":"Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis","volume":"108","author":"P Andre","year":"2003","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1161\/CIRCULATIONAHA.106.675587","article-title":"Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study","volume":"115","author":"PA Gurbel","year":"2007","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/jth.12318","article-title":"Pharmacogenomics in cardiovascular disease: focus on aspirin and ADP receptor antagonists","volume":"11","author":"M Wurtz","year":"2013","journal-title":"J Thromb Haemost"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/blood-2010-11-320788","article-title":"Identification of a specific intronic PEAR1 gene variant associated with greater platelet aggregability and protein expression","volume":"118","author":"N Faraday","year":"2011","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/ng.604","article-title":"Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists","volume":"42","author":"AD Johnson","year":"2010","journal-title":"Nat Genet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCGENETICS.111.964627","article-title":"Genetic Variation in PEAR1 is Associated with Platelet Aggregation and Cardiovascular Outcomes","volume":"6","author":"JP Lewis","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"24680","DOI":"10.1074\/jbc.M413411200","article-title":"Platelet endothelial aggregation receptor 1 (PEAR1), a novel epidermal growth factor repeat-containing transmembrane receptor, participates in platelet contact-induced activation","volume":"280","author":"N Nanda","year":"2005","journal-title":"J Biol Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1182\/blood-2011-11-392787","article-title":"A novel mechanism of sustained platelet alphaIIbbeta3 activation via PEAR1","volume":"119","author":"A Kauskot","year":"2012","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/CLEP.S10190","article-title":"Existing data sources for clinical epidemiology: The Western Denmark Heart Registry","volume":"2","author":"M Schmidt","year":"2010","journal-title":"Clin Epidemiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.2174\/138161212803251862","article-title":"Platelet function testing in atherothrombotic disease","volume":"18","author":"EL Grove","year":"2012","journal-title":"Curr Pharm Des"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.2174\/138161212803251907","article-title":"Pharmacogenetics of the antiplatelet effect of aspirin","volume":"18","author":"M Wurtz","year":"2012","journal-title":"Curr Pharm Des"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCULATIONAHA.107.700401","article-title":"Genetic association studies","volume":"118","author":"KL Lunetta","year":"2008","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation","volume":"29","author":"ST Sherry","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1538-7836.2009.03714.x","article-title":"Reduction of platelet thromboxane A2 production ex vivo and in vivo by clopidogrel therapy","volume":"8","author":"PC Armstrong","year":"2010","journal-title":"J Thromb Haemost"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1479-5876-6-46","article-title":"Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients","volume":"6","author":"KA Schwartz","year":"2008","journal-title":"J Transl Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e64179","DOI":"10.1371\/journal.pone.0064179","article-title":"Targeted deep resequencing identifies coding variants in the PEAR1 gene that play a role in platelet aggregation","volume":"8","author":"Y Kim","year":"2013","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1182\/blood-2012-10-462887","article-title":"PEAR1 attenuates megakaryopoiesis via control of the PI3K\/PTEN pathway","volume":"121","author":"A Kauskot","year":"2013","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/hrt.2009.181107","article-title":"The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease","volume":"96","author":"M Wurtz","year":"2010","journal-title":"Heart"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1161\/ATVBAHA.108.168971","article-title":"A novel variant in the platelet endothelial aggregation receptor-1 gene is associated with increased platelet aggregability","volume":"28","author":"JE Herrera-Galeano","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2125.2008.03183.x","article-title":"Pharmacogenetics of aspirin resistance: a comprehensive systematic review","volume":"66","author":"T Goodman","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jacc.2010.04.008","article-title":"Genotyping: one piece of the puzzle to personalize antiplatelet therapy","volume":"56","author":"PA Gurbel","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","article-title":"ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)","volume":"32","author":"CW Hamm","year":"2011","journal-title":"Eur Heart J"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature11632","article-title":"An integrated map of genetic variation from 1,092 human genomes","volume":"491","author":"GR Abecasis","year":"2012","journal-title":"Nature"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.thromres.2011.02.019","article-title":"Genetic determinants of response to aspirin: Appraisal of 4 candidate genes","volume":"128","author":"M Lordkipanidze","year":"2011","journal-title":"Thromb Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/gepi.20538","article-title":"Meta-analysis of genetic association studies and adjustment for multiple testing of correlated SNPs and traits","volume":"34","author":"KN Conneely","year":"2010","journal-title":"Genet Epidemiol"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Wurtz M, Hvas AM, Christensen KH, Rubak P, Kristensen SD, <etal>et al<\/etal>. (2013) Rapid evaluation of platelet function using the Multiplate(R) Analyzer. Platelets, 2013. doi:10.3109\/09537104.2013.849804.","DOI":"10.3109\/09537104.2013.849804"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1160\/TH11-03-0185","article-title":"Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel. Results from PRINCIPLE-TIMI 44","volume":"106","author":"AL Frelinger 3rd","year":"2011","journal-title":"Thromb Haemost"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.CIR.0000085073.69189.88","article-title":"Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects","volume":"108","author":"P Fontana","year":"2003","journal-title":"Circulation"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0111816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T13:21:19Z","timestamp":1540214479000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0111816"}},"subtitle":[],"editor":[{"given":"Ingo","family":"Ahrens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,31]]},"references-count":35,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0111816","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,31]]}}}